Phibro Animal Health (PAHC) Cash from Operations (QoQ) (2013 - 2026)
Phibro Animal Health (PAHC) Cash from Operations (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.58 Bn | 86.72 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.33 Bn | 30.39 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.29 Bn | 18.49 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.93 Bn | 16.62 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Phibro Animal Health | 1.42 Bn | 1.34 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.26% |
| Dec 31, 2025 | 108.04% |
| Sep 30, 2025 | -56.27% |
| Jun 30, 2025 | -50.71% |
| Mar 31, 2025 | 1,302.93% |
| Dec 31, 2024 | -75.63% |
| Sep 30, 2024 | -55.60% |
| Jun 30, 2024 | 149.20% |
| Mar 31, 2024 | -63.85% |
| Dec 31, 2023 | 94.81% |
| Sep 30, 2023 | -19.96% |
| Jun 30, 2023 | 223.34% |
| Mar 31, 2023 | 351.47% |
| Dec 31, 2022 | 76.73% |
| Sep 30, 2022 | -779.67% |
| Jun 30, 2022 | -74.33% |
| Mar 31, 2022 | -69.53% |
| Dec 31, 2021 | 426.62% |
| Sep 30, 2021 | 24.46% |
| Jun 30, 2021 | -81.53% |